По вашему запросу найдено документов: 44

Страница 1 из 5

Phase I/II trial of local interstitial chemotherapy with arsenic trioxide in patients with newly diagnosed glioma
Han, Dayong, Teng, Lei, Wang, Xiaoxiong, Zhen, Yunbo, Chen, Xiaofeng, Yang, Mingchun, Gao, Ming, Yang, Guang, Han, Mingyang, Wang, Ligang, Xu, Jiajun, Li, Yue, Shumadalova, Alina, Zhao, Shiguang (2022)
patients benefit from STUPP strategy, including maximum and safe resection and adjuvant radiotherapy
Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial
Burtness, B., Haddad, R., Dinis, J., Trigo, J., Yokota, T, De Souza Viana, L., Romanov, I., Vermorken, J., Bourhis, J., Tahara, M., Martins Segalla, J.G., Psyrri, A., Vasilevskaya, I., Nangia, C.S., Chaves-Conde, M., Kiyota, N., Homma, A., Holeckova, P., Del Campo, J.M., Asarawala, N., Nicolau, U.R., Rauch, D., Even, C., Wang, B., Gibson, N., Ehrnrooth, E., Harrington, K., Cohen, E.E.W. (2019)
of adjuvant afatinib after CRT is not recommended. © 2019 American Medical Association. All rights reserved.
Возможности профилактики тошноты при цитостатической терапии: обзор литературы и клиническое наблюдение
Possibilities of prevention of nausea during cytostatic therapy: literature review and clinical cases
Menshikov, Konstantin V., Musin, Shamil I., Sultanbaev, Alexander V., Nasretdinov, Ainur F., Sultanbaeva, Nadezda I., Menshikova, Irina A., Ayupov, Rustam T., Izmailov, Adel A., Меньшиков, К.В., Мусин, Ш.И., Султанбаев, А.В., Насретдинов, А.Ф., Султанбаева, Н.И., Меньшикова, И.А., Аюпов, Р.Т., Измайлов, А.А. (2023)
Platinum-based chemotherapy promotes antigen presenting potential in monocytes of patients with high-grade serous ovarian carcinoma
Larionova, Irina, Iamshchikov, Pavel, Kazakova, Anna, Rakina, Militsa, Menyalo, Maxim, Enikeeva, Kadriia, Rafikova, Guzel, Sharifyanova, Yuliya, Pavlov, Valentin, Villert, Alisa, Kolomiets, Larisa, Kzhyshkowska, Julia (2025)
-line treatment with platinum-based chemotherapy. At present, numerous clinical trials are being conducted
Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial
Kristeleit, Rebecca, Lisyanskaya, Alla, Fedenko, Alexander, Dvorkin, Mikhail, de Melo, Andreia Cristina, Shparyk, Yaroslav, Rakhmatullina, Irina, Bondarenko, Igor, Colombo, Nicoletta, Svintsitskiy, Valentyn, Biela, Luciano, Nechaeva, Marina, Lorusso, Domenica, Scambia, Giovanni, Cibula, David, Póka, Róbert, Oaknin, Ana, Safra, Tamar, Mackowiak-Matejczyk, Beata, Ma, Ling, Thomas, Daleen, Lin, Kevin K, McLachlan, Karen, Goble, Sandra, Oza, Amit M (2022)
(PARP) inhibitors to chemotherapy for the treatment of BRCA1-mutated or BRCA2-mutated ovarian carcinoma
Rucaparib versus chemotherapy for treatment of relapsed ovarian cancer with deleterious BRCA1 or BRCA2 mutation (ARIEL4): final results of an international, open-label, randomised, phase 3 trial
Oza, Amit M, Lisyanskaya, Alla, Fedenko, Alexander, de Melo, Andreia Cristina, Shparyk, Yaroslav, Rakhmatullina, Irina, Bondarenko, Igor, Colombo, Nicoletta, Svintsitskiy, Valentyn, Biela, Luciano, Nechaeva, Marina, Lorusso, Domenica, Scambia, Giovanni, Cibula, David, Póka, Róbert, Oaknin, Ana, Safra, Tamar, Mackowiak-Matejczyk, Beata, Ma, Ling, Thomas, Daleen, Lin, Kevin K, McLachlan, Karen, Goble, Sandra, Kristeleit, Rebecca (2025)
Background: In the ARIEL4 trial of rucaparib versus standard-of-care chemotherapy in patients
Cerebrovascular disorders in patients with malignant tumors
Beylerli, Ozal, Talybov, Rustam, Musaev, Elmar (2024)
Chemotherapy
ПОЗДНИЕ ОСЛОЖНЕНИЯ ЛЕЧЕНИЯ БОЛЬНЫХ ГЕРМИНОГЕННЫМИ ОПУХОЛЯМИ
Late complications of the treatment of patients with germ cell tumors
ДАНИЕЛЯН, Д.Г., САЛИМОВА, А.А., БУЛАНОВ, А.А., ФЕДЯНИН, М.Ю., ТРЯКИН, А.А., DANIELYAN D.G., SALIMOVA A.A., BULANOV A.A., FEDYANIN M. YU., TRYAKIN A.A. (2020)
CHEMOTHERAPY
Наследственные формы злокачественных новообразований молочных желез: прогноз, скрининг и профилактика. Обзор литературы
Hereditary forms of breast malignant neoplasms: prognosis, screening and prevention. A review
Sultanbaev, Alexander V., Kolyadina, Irina V., Gilyazova, Irina R., Nasretdinov, Ainur F., Musin, Shamil I., Sultanbaeva, Nadezda I., Menshikov, Konstantin V., Султанбаев, А.В., Колядина, И.В., Гилязова, И.Р., Насретдинов, А.Ф., Мусин, Ш.И., Султанбаева, Н.И., Меньшиков, К.В. (2024)
intensive screening programs in this population. Pathogenetic adjuvant therapy with olaparib significantly
Место и роль болезнь-модифицирующей терапии и адъювантной поддержки в комплексной терапии хронической неспецифической боли в нижней части спины. Резолюция мультидисциплинарного совета экспертов
Disease-modifying therapy and adjuvant support in complex therapy of chronic non-specific low back pain. Resolution of the Multidisciplinary Board of Experts
Алексеева, Л.И., Барулин, А.Е., Бахтадзе, М.А., Давыдов, О.С., Девликамова, Ф.И., Калинский, П.П., Кукушкин, М.Л., Курушина, О.В., Минасов, Т.Б., Сарвилина, И.В., Чурюканов, М.В., Alekseeva, L.I., Barulin, A.E., Bakhtadze, M.A., Davydov, O.S., Devlikamova, F.I., Kalinsky, P.P., Kukushkin, M.L., Kurushina, O.V., Minasov, T.B., Sarvilina, I.V., Churyukanov, M.V. (2024)
Disease-modifying therapy and adjuvant support in complex therapy of chronic non-specific low back

Страница 1 из 5

Google Scholar
OpenDoar

Фасеты

Авторы
Ключевые слова
Год